MAP3K8 and neoplasm: Pharmacological inhibition of MET in Tpl2-/- mice is somewhat effective, decreasing overall tumor burden and conversion to cSCC, but doesn’t completely eliminate tumor growth or restore numbers to the level of wild type controls [25].